APLNR modulators and uses thereof
US-10155811-B2 · Dec 18, 2018 · US
for hormones {(for neuromediators C07K14/70571)}
for hormones {(for neuromediators C07K14/70571)} · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/72 |
| Official title | for hormones {(for neuromediators C07K14/70571)} |
| Display label | for hormones {(for neuromediators C07K14/70571)} |
| Total patents | 244 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 19 |
| 2017 | 15 |
| 2018 | 18 |
| 2019 | 30 |
| 2020 | 25 |
| 2021 | 29 |
| 2022 | 26 |
| 2023 | 21 |
| 2024 | 29 |
| 2025 | 19 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Peptide ligands for hepatic stellate cells
US-10138273-B2 · Nov 27, 2018 · US
Methods for screening for binding partners of G-protein coupled receptors
US-10126313-B2 · Nov 13, 2018 · US
Novel estrogen receptor mutations and uses thereof
US-2018320238-A1 · Nov 8, 2018 · US
Composition for the prevention, improvement, or treatment of neurological disorder including adiponectin receptor-activating novel peptide as active ingredient
US-2018312540-A1 · Nov 1, 2018 · US
Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist
US-2018311315-A1 · Nov 1, 2018 · US
Estrogen receptor mutations and uses thereof
US-10093983-B2 · Oct 9, 2018 · US
Polypeptides Capable of Inhibiting the Binding Between Leptin and Neuropilin-1
US-2018230189-A1 · Aug 16, 2018 · US
Regulation of specific spinal neurons regulating pain transmission via chimeric toxins
US-10022450-B2 · Jul 17, 2018 · US
Methods of treating prlr positive breast cancer
US-2018185504-A1 · Jul 5, 2018 · US
Methods of treating cancer by identification of patients sensitive to fgfr inhibitor therapy
US-2018180628-A1 · Jun 28, 2018 · US
Antigen-binding proteins that antagonize leptin receptor
US-2018127508-A1 · May 10, 2018 · US
Selective inhibitor of angiotensin II
US-9944677-B2 · Apr 17, 2018 · US
Follistatin fusion proteins and uses thereof
US-9919030-B2 · Mar 20, 2018 · US
Chimeric proteins and methods of regulating gene expression
US-9856497-B2 · Jan 2, 2018 · US
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
US-2017362572-A1 · Dec 21, 2017 · US
Blockers of the growth hormone receptor in disease prevention and treatment
US-2017342063-A1 · Nov 30, 2017 · US
Conditionally active heterodimeric polypeptides and methods of use thereof
US-2017306303-A1 · Oct 26, 2017 · US
Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease and assess disease severity
US-9797901-B2 · Oct 24, 2017 · US
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
US-9783592-B2 · Oct 10, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/72?
- CPC C07K14/72 is the Cooperative Patent Classification code for “for hormones {(for neuromediators C07K14/70571)}.”
- How many patents are filed under CPC C07K14/72 (for hormones {(for neuromediators C07K14/70571)})?
- Our database includes 244 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/72 growing?
- Publication counts under this code: 29 in 2024 vs 19 in 2025 (latest complete years).